
<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections - Shiu, JR - 2013 | Cochrane Library</title> <meta property="og:title" content="Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections - Shiu, JR - 2013 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008481.pub2/full" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD008481.pub2" /> <meta name="citation_title" content="Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections" /> <meta name="citation_author" content="Jennifer R Shiu" /> <meta name="citation_author_institution" content="Alberta Health Services" /> <meta name="citation_author" content="Erica Wang" /> <meta name="citation_author_institution" content="Interior Health Authority" /> <meta name="citation_author" content="Aaron M Tejani" /> <meta name="citation_author_institution" content="University of British Columbia" /> <meta name="citation_author_email" content="Aaron.Tejani@fraserhealth.ca" /> <meta name="citation_author" content="Michael Wasdell" /> <meta name="citation_author_institution" content="Bridgepoint Collaboratory for Research and Innovation Bridgepoint Health" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="3" /> <meta name="citation_doi" content="10.1002/14651858.CD008481.pub2" /> <meta name="citation_date" content="2013" /> <meta name="citation_online_date" content="2013/03/28" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008481.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008481.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008481.pub2/pdf/full" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Acute Disease; Anti‐Bacterial Agents [*administration &amp; dosage, pharmacokinetics]; Bacterial Infections [*drug therapy, metabolism, mortality]; Infusions, Intravenous [methods]; Randomized Controlled Trials as Topic; Recurrence" /> <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script>  <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-HANS" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_HANT&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-HANT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;full&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1634809370000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1634809370000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" rel="stylesheet" type="text/css" /> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" rel="stylesheet" type="text/css" /> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1637060992000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 96},getRevision:function(){return"537.36"},getVersion:function(){return"96.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return true},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="zrkx755e";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008481\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008481\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008481.pub2",title:"Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections",firstPublishedDate:"Mar 28, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Injuries Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1634809370000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1634809370000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zrkx755e&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008481.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008481.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh_HANT, zh_HANS]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT" class="content-language-selector " data-languagecode="zh_HANT">繁體中文</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS" class="content-language-selector " data-languagecode="zh_HANS">简体中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD008481.pub2/full/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD008481.pub2/full/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008481.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
Cochrane Database of Systematic Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_198" role="presentation">
<a aria-labelledby="layout_198" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorial-policies" role="menuitem">
Editorial policies
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;cochranesupport&#x2e;wiley&#x2e;com&#x2f;s&#x2f;article&#x2f;cochrane-library-known-issues" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD008481.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD008481.pub2/#" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008481.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008481.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <div class="metrics-wrapper"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008481.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Used in $1 guidelines" data-count-single="Used in 1 guideline"> <a href="related-content#guidelines_data"></a> </div> </div> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link " lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-sec1-0006"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/appendices#CD008481-sec1-0012"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#history"> Version History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/table_n/CD008481StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/table_n/CD008481StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic Reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 lang="en" class="publication-title">Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#CD008481-cr-0002">Jennifer R Shiu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#CD008481-cr-0003">Erica Wang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#CD008481-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Aaron M Tejani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information#CD008481-cr-0005">Michael Wasdell</a></li> </ul> <span class="author declaration"> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information/en#CD008481-sec1-0015" class="declarationsOfInterestLink">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 March 2013 </span> <a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/information/en#versionTable" class="whatsNewLink">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008481.pub2">https://doi.org/10.1002/14651858.CD008481.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008481-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008481-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008481-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008481-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008481-abs-0001" lang="en"> <section id="CD008481-abs1-0001"> <h3 class="title" id="CD008481-abs1-0001">Background</h3> <p>Intravenous broad–spectrum antibiotics are indicated for the treatment of severe infections.&nbsp;However, the emergence of infections caused by multiple‐drug resistant organisms in conjunction with a lack of novel antibiotics has prompted the investigation of alternative dosing strategies to improve clinical efficacy and tolerability.&nbsp;To optimise pharmacokinetic and pharmacodynamic antibiotic parameters, continuous antibiotic infusions have been compared with traditional intermittent antibiotic infusions. </p> </section> <section id="CD008481-abs1-0002"> <h3 class="title" id="CD008481-abs1-0002">Objectives</h3> <p>To compare the clinical efficacy and safety of continuous intravenous administration of concentration–dependent and time–dependent antibiotics with traditional intermittent intravenous administration in adults with severe acute bacterial infections.&nbsp; </p> </section> <section id="CD008481-abs1-0003"> <h3 class="title" id="CD008481-abs1-0003">Search methods</h3> <p>The following electronic databases were searched in September 2012: The Cochrane Injuries Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), <i>The Cochrane Library</i>, MEDLINE (OvidSP), EMBASE (OvidSP), CINAHL, ISI Web of Science: Science Citation Index Expanded (SCI‐EXPANDED), and ISI Web of Science: Conference Proceedings Citation Index‐Science (CPCI‐S). The reference lists of all relevant materials, the Internet, and the trials registry <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a> for completed and ongoing trials were also searched. </p> </section> <section id="CD008481-abs1-0004"> <h3 class="title" id="CD008481-abs1-0004">Selection criteria</h3> <p>Randomised controlled trials in adults with a bacterial infection requiring intravenous antibiotic therapy comparing continuous versus intermittent infusions of antibiotics were included.&nbsp;Both time–dependent and concentration–dependent antibiotics were considered. </p> </section> <section id="CD008481-abs1-0005"> <h3 class="title" id="CD008481-abs1-0005">Data collection and analysis</h3> <p>Three independent authors performed data extraction for the included studies.&nbsp;All data were cross–checked and disagreements resolved by consensus.&nbsp;An intention‐to‐treat analysis was conducted using a random–effects model. </p> </section> <section id="CD008481-abs1-0006"> <h3 class="title" id="CD008481-abs1-0006">Main results</h3> <p>Twenty–nine studies met inclusion criteria with a combined total of more than 1600 participants. Most included studies were judged to be at unclear or high risk of bias with regard to randomisation sequence generation, allocation concealment, blinding, management of incomplete outcome data, selective outcome reporting, and other potential threats to validity. No studies were judged to be at low risk of bias for all methodological quality items assessed. No differences in all–cause mortality (n = 1241, risk ratio (RR) 0.89, 95% confidence interval (CI) 0.67 to 1.20, P = 0.45), infection recurrence (n = 398, RR 1.22, 95% CI 0.35 to 4.19, P = 0.76), clinical cure (n = 975, RR 1.00, 95% CI 0.93 to 1.08, P = 0.98), and super‐infection post–therapy (n = 813, RR 1.08, 95% CI 0.60 to 1.94, P = 0.79) were reported, nor were any differences observed in safety outcomes, including adverse events (n = 575, RR 1.02, 95% CI 0.94 to 1.12, P = 0.63), serious adverse events (n = 871, RR 1.36, 95% CI 0.80 to 2.30, P = 0.26), and withdrawals due to adverse events (n = 871, RR 2.03, 95% CI 0.52 to 7.95, P = 0.31). A difference was observed in subgroup analyses of clinical cure in septic versus non‐septic participants, ckd cockroft gault, ckd staging mdrd, in children modified schwartz bedside, aki jellife or braker or chen formula, cohort for future, case report for drugs in which intermittent antibiotic infusions were favoured for clinical cure in septic participants. However, this effect was not consistent between random‐effects and fixed‐effect analyses. No differences were noted in the sensitivity analyses conducted.</p> </section> <section id="CD008481-abs1-0007"> <h3 class="title" id="CD008481-abs1-0007">Authors' conclusions</h3> <p>No differences in mortality, infection recurrence, clinical cure, super‐infection post–therapy, and safety outcomes were reported when continuous infusions of intravenous antibiotics were compared with traditional intermittent infusions of antibiotics.&nbsp;However, the wide confidence intervals suggest that beneficial or harmful effects cannot be ruled out for all outcomes. Therefore, the current evidence is insufficient to recommend the widespread adoption of continuous infusion antibiotics in the place of intermittent infusions of antibiotics.&nbsp;Additinal large prospective randomised trials, with consistent and complete reporting of clinical outcome measures, conducted with concurrent pharmacokinetic and pharmacodynamic studies in special populations, are required to determine whether adoption of continuous antibiotic infusions is warranted in specific circumstances. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008481-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008481-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008481-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008481-abs-0005">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008481-abs-0004" lang="en"> <h3>Alternative dosing strategies for intravenous antibiotics to treat severe infections</h3> <p>Intravenous (through the vein) antibiotics are used to treat severe bacterial infections. Currently, the most common way to administer intravenous antibiotics is by intermittent infusion, whereby an antibiotic is infused into a patient over 30 minutes to 1 hour multiple times per day during the course of treatment.&nbsp;To optimise the efficacy and potentially the safety of these antibiotics, alternative dosing strategies have been studied.&nbsp;One proposed strategy is to administer intravenous antibiotics by continuous or extended infusions over 3 to 24 hours.&nbsp; </p> <p>Twenty–nine randomised trials comprising more than 1600 participants were reviewed to study the effects of continuous infusion antibiotics versus intermittent infusion antibiotics.&nbsp;When mortality, infection recurrence, clinical cure, super‐infection after treatment, and safety concerns were considered, no differences between the two dosing strategies were noted. </p> <p>The authors conclude that because continuous antibiotic infusions provide no benefit over standard intermittent infusions, they cannot recommend continuous antibiotic infusions for widespread use. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img src="" alt="visual summary" /></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008481-sec1-0007" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008481-sec1-0007"></div> <h3 class="title" id="CD008481-sec1-0008">Implications for practice</h3> <section id="CD008481-sec1-0008"> <p>No differences in mortality, infection recurrence, clinical cure, and super‐infection post–therapy were found when continuous infusions of intravenous antibiotics were compared with traditional intermittent antibiotic infusions.&nbsp;However, the wide confidence intervals suggest that beneficial or harmful effects cannot be ruled out for all outcomes. Although no evidence of statistical heterogeneity was found, some clinically meaningful heterogeneity between studies is likely and should be considered.&nbsp;Also, no differences in safety outcomes between the two interventions were apparent. Because several trials did not report data for clinically important outcomes, and because confidence intervals for effect estimates were wide, it is possible that the analyses in this review are underpowered because of lack of data. Therefore, the current available evidence is insufficient to recommend the widespread adoption of continuous infusion antibiotics in the place of standard intermittent antibiotic infusions. </p> </section> <h3 class="title" id="CD008481-sec1-0009">Implications for research</h3> <section id="CD008481-sec1-0009"> <p>Large, prospective randomised trials looking at additional outcomes, such as length of hospital stay, and reporting on all outcomes of interest as outlined in this review, would add to the findings of this review.&nbsp;It would also be helpful if these large trials were conducted with concurrent pharmacokinetic and pharmacodynamic studies. Trials investigating the effects of continuous infusion antibiotics in critically ill participants should be considered, because this population is theoretically more likely to benefit from this alternate dosing strategy based on subgroup data from previous retrospective studies. It is also not clear whether there would be additional therapeutic efficacy if continuous antibiotic infusions were used to treat more resistant organisms.&nbsp;Additional pharmacoeconomic studies are required to confirm whether there are other reasons to support the use of continuous infusion antibiotics. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008481-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008481-sec1-0001"></div> <div class="table" id="CD008481-tbl-0001"> <table class="summary-of-findings framed"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Continuous versus Intermittent Antibiotic Infusions for Treatment of Severe Bacterial Infections</span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Continuous versus Intermittent Antibiotic Infusions for Treatment of Severe Bacterial Infections</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patients:</b> Adults with Severe Bacterial Infections<br> <b>Setting:</b> Hospital<br> <b>Intervention:</b> Continuous Antibiotic Infusions<br> <b>Comparison:</b> Intermittent Antibiotic Infusions </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Intermittent antibiotic Infusions</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Continuous antibiotic Infusions</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>131 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>116 per 1000</b> <br> (88 to 157) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.89</b> <br> (0.67 to 1.20) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1241<br> (19 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br> <b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Infection recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>19 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>24 per 1000</b> <br> (7 to 81) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.22</b> <br> (0.35 to 4.19) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>398<br> (8 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Clinical cure</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>584 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>608 per 1000</b> <br> (555 to 660) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.04</b> <br> (0.95 to 1.13) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>975<br> (15 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Super‐infection</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>49 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>53 per 1000</b> <br> (29 to 95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.08</b> <br> (0.60 to 1.94) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>813<br> (12 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Serious adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>48 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>65 per 1000</b> <br> (38 to 110) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.36</b> <br> (0.80 to 2.30) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>871<br> (10 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Withdrawal due to adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>7 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>14 per 1000</b> <br> (4 to 54) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 2.03</b> <br> (0.52 to 7.95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>871<br> (10 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>441 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>450 per 1000</b> <br> (415 to 494) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.02</b> <br> (0.94 to 1.12) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>575<br> (5 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008481-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008481-sec1-0002"></div> <section id="CD008481-sec2-0001"> <h3 class="title" id="CD008481-sec2-0001">Description of the condition</h3> <p>Intravenous broad–spectrum antibiotics are indicated for the treatment of severe community–acquired or healthcare–associated infection.&nbsp;However, the emergence of multiple–drug resistant infections caused by organisms such as <i>Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterococcus faecium, Enterococcus faecalis,</i> and Enterobacteriaceae is growing worldwide (<a href="./references#CD008481-bbs2-0094">Rosenthal 2012</a>; <a href="./references#CD008481-bbs2-0074">Ghafourian 2011</a>; <a href="./references#CD008481-bbs2-0086">Meyer 2011</a>; <a href="./references#CD008481-bbs2-0088">Neidell 2012</a>).&nbsp;Such antimicrobial–resistant infections have been associated with poor outcomes, such as increases in length of hospital stay, healthcare costs, and mortality (<a href="./references#CD008481-bbs2-0095">Sunenshine 2007</a>; <a href="./references#CD008481-bbs2-0088">Neidell 2012</a>).&nbsp;Despite this growing problem, few novel antibiotics have been developed in recent years; therefore, alternative dosing strategies have been investigated to improve clinical efficacy while ensuring tolerability. To optimise the pharmacokinetic and pharmacodynamic properties of antibiotics, dosing strategies such as continuous or extended intravenous antibiotic infusions have been compared with traditional intermittent intravenous antibiotic dosing. </p> </section> <section id="CD008481-sec2-0002"> <h3 class="title" id="CD008481-sec2-0002">Description of the intervention</h3> <p>Antibiotics are divided into categories on the basis of the pharmacokinetic and pharmacodynamic parameters associated with antibacterial efficacy. Although these bacterial kill characteristics have been determined most often from in vitro studies, this information remains important in optimising antibiotic clinical efficacy.&nbsp;For example, aminoglycosides, fluoroquinolones, and metronidazole are classified as concentration–dependent antibiotics, for which efficacy is determined by peak plasma drug concentration over minimum inhibitory concentration (Cmax/MIC) (<a href="./references#CD008481-bbs2-0091">Roberts 2006</a>; <a href="./references#CD008481-bbs2-0071">Craig 1998</a>; <a href="./references#CD008481-bbs2-0087">Moore 1987</a>).&nbsp;Conversely, beta–lactams, carbapenems, clindamycin, linezolid, and clarithromycin are time–dependent or concentration–independent antibiotics for which the time the drug serum concentration remains above the minimum inhibitory concentration (T &gt; MIC) is the best predictor of efficacy (<a href="./references#CD008481-bbs2-0091">Roberts 2006</a>; <a href="./references#CD008481-bbs2-0085">McKinnon 2008</a>; <a href="./references#CD008481-bbs2-0071">Craig 1998</a>; <a href="./references#CD008481-bbs2-0097">van Zanten 2009</a>).&nbsp;Although it is commonly accepted that antibiotics are divided into two main classifications, some antimicrobials exhibit more complex bacterial kill characteristics.&nbsp;Fluoroquinolones, azithromycin, glycopeptides, and tetracyclines are concentration–dependent antibiotics with time dependence, for which efficacy is best predicted by the area under the serum concentration–time curve during 24 hours over the minimum inhibitory concentration (AUC<sub>24</sub>/MIC) (<a href="./references#CD008481-bbs2-0091">Roberts 2006</a>; <a href="./references#CD008481-bbs2-0071">Craig 1998</a>). </p> <p>Studies evaluating the efficacy of continuous or extended antibiotic infusions generally involve time–dependent antibiotics (<a href="./references#CD008481-bbs2-0004">Buck 2005</a>; <a href="./references#CD008481-bbs2-0092">Roberts 2008</a>; <a href="./references#CD008481-bbs2-0093">Roberts 2009a</a>).&nbsp;Several time–dependent antibiotics are known to have a short half‐life; therefore, concern has arisen that the drug serum concentration will drop below the minimum inhibitory concentration (MIC) before the next scheduled intermittent infusion (<a href="./references#CD008481-bbs2-0082">Lipman 2001</a>).&nbsp;To optimise antibiotic kill characteristics, extended (&gt; 3‐hour intermittent infusions) or continuous (24‐hour fixed–rate infusions) administration is thought to prolong T &gt; MIC and to improve clinical efficacy (<a href="./references#CD008481-bbs2-0096">Tamma 2011</a>; <a href="./references#CD008481-bbs2-0083">Lodise 2006</a>).&nbsp;Although T &gt; MIC targets vary between antibiotic classes (20% to 40% carbapenems, 50^ to 60% penicillins, 60% to 70% cephalosporins, 50% to 60% monobactams) (<a href="./references#CD008481-bbs2-0071">Craig 1998</a>; <a href="./references#CD008481-bbs2-0072">Drusano 2004</a>), improved clinical cure rates and bacteriologic eradication were observed in critically ill participants when T &gt; MIC was maintained at 100% (<a href="./references#CD008481-bbs2-0085">McKinnon 2008</a>).&nbsp;It has also been suggested in comparison with intermittent infusions of vancomycin and beta–lactams, continuous infusions may reduce time to achieve therapeutic drug serum concentrations (<a href="./references#CD008481-bbs2-0092">Roberts 2008</a>).&nbsp;In contrast, for concentration–dependent antibiotics that exhibit post–antibiotic effects, it is not known whether extended or continuous infusions would be of additional benefit because large, infrequent infusions would maximize Cmax/MIC, resulting in peak efficacy. However, for select concentration‐dependent antibiotics in which efficacy is also characterized by AUC<sub>24</sub>/MIC (e.g. fluoroquinolones), extended or continuous infusions may result in favourable clinical outcomes. </p> </section> <section id="CD008481-sec2-0003"> <h3 class="title" id="CD008481-sec2-0003">Why it is important to do this review</h3> <p>Previous reviews have suggested that continuous or extended infusion of time–dependent antibiotics results in more favourable pharmacodynamic outcomes.&nbsp;A systematic review of 17 randomised clinical trials performed by Kasiakou et al compared the pharmacokinetic and pharmacodynamic parameters of intermittent and continuous infusions of time–dependent antibiotics in hospitalised adults and in healthy volunteers (<a href="./references#CD008481-bbs2-0080">Kasiakou 2005a</a>).&nbsp;It was found that the mean Cmax of the intermittent infusion group was 5.5 times greater than the steady–state serum concentration (Css) of the continuous infusion group (range 1.9 to 11.2). Additionally, the Css of the continuous infusion group was 5.8 times higher than the trough serum concentration (Cmin) of the intermittent infusion group (range 1.2 to 15.6).&nbsp;Investigators also observed that the T &gt; MIC was longer in the continuous infusion group in three of the six studies included. </p> <p>Although it is of theoretical advantage to administer time–dependent antibiotics by continuous or extended infusion, several systematic reviews investigating this issue have not confirmed these proposed clinical benefits.&nbsp;A meta–analysis of nine randomised controlled trials (RCTs) performed by Kasiakou et al to compare continuous versus intermittent administration of beta–lactams, aminoglycosides, and vancomycin showed no difference in clinical failure (odds ratio (OR) 0.73, 95% CI 0.53 to 1.01) or mortality (OR 0.89, 95% CI 0.48 to 1.64) (<a href="./references#CD008481-bbs2-0081">Kasiakou 2005b</a>).&nbsp;However, a subgroup analysis of those RCTs that used the same daily antibiotic dose in both intervention groups showed reduced clinical failure in the continuous infusion arm (OR 0.70, 95% CI 0.50 to 0.98) (<a href="./references#CD008481-bbs2-0081">Kasiakou 2005b</a>). A systematic review of 14 RCTs conducted by Tamma et al in hospitalised patients showed that prolonged beta–lactam infusions rather than intermittent infusions did not affect mortality (n = 982, RR 0.92, 95% CI 0.61 to 1.37) or clinical cure (n = 1380, RR 1.00, 95% CI 0.94 to 1.06) (<a href="./references#CD008481-bbs2-0096">Tamma 2011</a>).&nbsp;Another systematic review of 14 RCTs including 846 hospitalised patients from 9 countries also showed that continuous or extended infusion beta–lactam infusions versus bolus dosing led to no improvement in clinical cure (n = 745, OR 1.04, 95% CI 0.74 to 1.46, P = 0.83) or mortality (n = 541, OR 1.00, 95% CI 0.48 to 2.06, P = 1.00) (<a href="./references#CD008481-bbs2-0093">Roberts 2009a</a>). These systematic reviews were generally well conducted; however, they were limited by small sample sizes, clinical heterogeneity in participants and infections studied, and study designs that were not blind. </p> <p>Investigators reported some improvement in pharmacodynamic outcomes with weak evidence supporting clinical benefits of continuous or extended infusion antibiotics. Therefore, the purpose of this review will be to determine whether any advantage is derived from using this alternative dosing strategy rather than conventional dosing strategies in patients with severe infection.&nbsp;In addition to evaluating clinical and safety outcomes of continuous versus intermittent dosing of time–dependent antibiotics, this review will be extended to include concentration–dependent antibiotics. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008481-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008481-sec1-0003"></div> <p>To compare the clinical efficacy and safety of continuous intravenous administration of concentration‐dependent and time‐dependent antibiotics with traditional intermittent intravenous administration in patients with severe acute bacterial infection. Continuous intravenous infusions included extended and continuous infusions. Severe acute infection was defined as any infection requiring intravenous antibiotics. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008481-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008481-sec1-0004"></div> <section id="CD008481-sec2-0004"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008481-sec3-0001"> <h4 class="title">Types of studies</h4> <p>Open‐label or blinded parallel‐group RCTs comparing continuous versus intermittent intravenous infusions of the same antibiotic were included. Cross‐over studies were excluded. </p> </section> <section id="CD008481-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Study participants were male or non‐pregnant female adults (18 years or older) with a bacterial infection requiring intravenous antibiotic therapy. Investigators considered different infections in this review, and no restrictions were placed on the anatomical site of infection, participant baseline risk, or co‐morbid conditions. </p> </section> <section id="CD008481-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>Included studies compared continuous versus intermittent infusions of the same intravenous antibiotic. Both time‐dependent and concentration‐dependent antibiotics were included. </p> </section> <section id="CD008481-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD008481-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD008481-lst1-0001"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Infection recurrence within 14 days of resolution of primary infection.</p> </li> </ul> </p> </section> <section id="CD008481-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD008481-lst1-0002"> <li> <p>Clinical cure (any pre‐defined criteria specific to the infection being studied that address signs and symptoms of infection, such as fever, leukocyte counts, bacterial culture results, vital signs and visual signs or symptoms of infection, such as sputum production or inflammation, redness, or size of skin lesion). </p> </li> </ul> <ul id="CD008481-lst1-0003"> <li> <p>Secondary/super‐infections post‐therapy (new infection with different organisms from those observed in the primary infection). </p> </li> </ul> <ul id="CD008481-lst1-0004"> <li> <p>Safety:</p> <ul id="CD008481-lst2-0001"> <li> <p>Number of participants who experienced at least one serious adverse event (results in death, is life threatening, places the participant at immediate risk of death, requires or prolongs hospitalisation, causes permanent/significant disability or incapacity, or is another condition that investigators judge to represent significant hazards). </p> </li> <li> <p>Number of participants who withdrew as the result of adverse events.</p> </li> <li> <p>Number of participants with at least one adverse event.</p> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD008481-sec2-0005"> <h3 class="title">Search methods for identification of studies</h3> <p>The searches were not restricted by date, language, or publication status.</p> <section id="CD008481-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>The following electronic databases were searched;</p> <p> <ul id="CD008481-lst1-0005"> <li> <p>Cochrane Injuries Group Specialised Register (13 September 2012).</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL)<i>(The Cochrane Library)</i> 2012<i>,</i> Issue 8 of 12. </p> </li> <li> <p>MEDLINE (OvidSP) 1946 to September Week 1 2012.</p> </li> <li> <p>EMBASE (OvidSP) 1980 to 2012 Week 37.</p> </li> <li> <p>CINAHL (EBSCO) (1982 to September 2012).</p> </li> <li> <p>ISI Web of Science: Science Citation Index Expanded (SCI‐EXPANDED) (1970 to 13 September 2012). </p> </li> <li> <p>ISI Web of Science: Conference Proceedings Citation Index‐Science (CPCI‐S) (1990 to 13 September 2012). </p> </li> </ul> </p> <p>Searches were based on the MEDLINE search strategy reported in the protocol, and amendments were made, when necessary, to adapt it for the other databases. All search strategies are reported in full in <a href="./appendices#CD008481-sec2-0015">Appendix 1</a>. </p> </section> <section id="CD008481-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>A manual search of reference lists of all relevant material was performed to identify additional potentially eligible studies. The Internet was searched using the Google search engine (<a href="http://www.google.com" target="_blank">www.google.com</a>), with selected terms from the MEDLINE strategy, to identify any further unpublished or grey literature. An online clinical trials register (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) was searched for completed and ongoing trials, and authors were contacted for information about ongoing or recently completed trials. </p> </section> </section> <section id="CD008481-sec2-0006"> <h3 class="title" id="CD008481-sec2-0006">Data collection and analysis</h3> <p>The Injuries Group Trials Search Co‐ordinator conducted the search using the methods described and collated the results before sending them to the authors. The review was conducted according to the previously published protocol (<a href="./references#CD008481-bbs2-0099">Yu 2010</a>). </p> <section id="CD008481-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>Four independent authors (JS, EW, AT, MW) screened the titles and abstracts of the search results. Studies not meeting the pre‐defined inclusion criteria were excluded. Reasons for excluding studies that seemed to meet the inclusion criteria, but then were subsequently excluded, were documented. Studies that met the inclusion criteria were further examined. The full text of all studies that were potentially relevant was retrieved and, where necessary, was translated into English. Studies with more than one publication were examined closely to ensure that each study was counted only once, and that multiple references were included by study. </p> </section> <section id="CD008481-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>Three independent authors (JS, EW, AT) used a pre‐formed standardised data extraction sheet to record study characteristics and outcomes considered for this review. All data were cross‐checked, and differences were resolved with further examination until a consensus was reached. The data extracted from each study included the following: </p> <p> <ul id="CD008481-lst1-0006"> <li> <p>Participant characteristics (e.g. gender, age, ethnicity, co‐morbid conditions).</p> </li> <li> <p>Methods (e.g. random allocation procedures; allocation concealment; blinding of participants, healthcare providers, and outcome assessors). </p> </li> <li> <p>Losses to follow‐up, how they were handled, and follow‐up duration.</p> </li> <li> <p>Interventions (including antibiotic used, dose, and duration).</p> </li> <li> <p>Outcome measures as listed previously.</p> </li> </ul> </p> <p>All data were collected, regardless of compliance or completion of follow‐up, to allow for an intention‐to‐treat analysis. </p> </section> <section id="CD008481-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three independent authors (JS, EW, AT) assessed the methodological quality of each study using the following parameters as an evaluation tool and transcribed information from each included study into the 'Risk of bias' tables. Criteria for assessing risk of bias included evaluating the sequence generation, allocation concealment, blinding, management of incomplete data, selective outcome reporting, and other potential threats to the validity of the studies (<a href="./references#CD008481-bbs2-0078">Higgins 2009</a>). </p> <section id="CD008481-sec4-0003"> <h5 class="title">Sequence generation</h5> <p>Was sequence generation adequate?</p> <p> <ul id="CD008481-lst1-0007"> <li> <p>Low risk of bias: A random component of sequence generation is described (e.g. computer‐generated random sequence, random number table). </p> </li> <li> <p>High risk of bias: A non‐random component of sequence generation is described (e.g. allocation by clinician's judgement, allocation by participant's preference, sequence generated by admission date). </p> </li> <li> <p>Unclear: insufficient information to conclude 'low risk of bias' or 'high risk of bias.' </p> </li> </ul> </p> </section> <section id="CD008481-sec4-0004"> <h5 class="title">Allocation concealment</h5> <p>Was allocation concealment adequate?</p> <p> <ul id="CD008481-lst1-0008"> <li> <p>Low risk of bias: Participants and investigators enrolling participants could not predict assignment (e.g. sequentially numbered opaque sealed envelopes, telephone randomisation). </p> </li> <li> <p>High risk of bias: Participants and investigators enrolling participants could predict assignment (e.g. unsealed envelopes, alternation). </p> </li> <li> <p>Unclear: Information is insufficient to allow conclusion of 'low risk of bias' or 'high risk of bias.' </p> </li> </ul> </p> </section> <section id="CD008481-sec4-0005"> <h5 class="title">Blinding of participants, personnel, and outcome assessors</h5> <p>Was blinding of individuals involved in the study (participants, personnel, and outcome assessors) to the treatment allocation adequate? </p> <p> <ul id="CD008481-lst1-0009"> <li> <p>Low risk of bias—any of the following:</p> <ul id="CD008481-lst2-0002"> <li> <p>No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding. </p> </li> <li> <p>Blinding of participants and key study personnel ensured; unlikely that the blinding could have been broken. </p> </li> <li> <p>Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non‐blinding of others unlikely to introduce bias. </p> </li> </ul> </li> <li> <p>High risk of bias—any of the following:</p> <ul id="CD008481-lst2-0003"> <li> <p>No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding. </p> </li> <li> <p>Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken. </p> </li> <li> <p>Either participants or some key study personnel were not blinded, and the non‐blinding of others is likely to introduce bias. </p> </li> </ul> </li> <li> <p>Unclear: insufficient information allow conclusion of 'low risk of bias' or 'high risk of bias.' </p> </li> </ul> </p> </section> <section id="CD008481-sec4-0006"> <h5 class="title">Incomplete outcome data</h5> <p>Were incomplete outcome data adequately addressed?</p> <p> <ul id="CD008481-lst1-0010"> <li> <p>Low risk of bias－any of the following:</p> <ul id="CD008481-lst2-0004"> <li> <p>No missing outcome data.</p> </li> <li> <p>Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias). </p> </li> <li> <p>Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups. </p> </li> <li> <p>For dichotomous outcomes data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate. </p> </li> <li> <p>For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size. </p> </li> <li> <p>Missing data have been imputed using appropriate method.</p> </li> </ul> </li> <li> <p>High risk of bias－any of the following:</p> <ul id="CD008481-lst2-0005"> <li> <p>Reason for missing outcome data likely to be related to true outcome, with imbalance in numbers of or reasons for missing data across intervention groups. </p> </li> <li> <p>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate. </p> </li> <li> <p>For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size. </p> </li> <li> <p>'As‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation. </p> </li> <li> <p>Potentially inappropriate application of simple imputation.</p> </li> </ul> </li> <li> <p>Unclear: insufficient reporting of attrition/exclusions to conclude 'low risk of bias' or 'high risk of bias' </p> </li> </ul> </p> </section> <section id="CD008481-sec4-0007"> <h5 class="title">Selective outcome reporting</h5> <p>Are reports of the study free of selective outcome reporting?</p> <p> <ul id="CD008481-lst1-0011"> <li> <p>Low risk of bias－any of the following:</p> <ul id="CD008481-lst2-0006"> <li> <p>Study protocol is available and all pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way. </p> </li> <li> <p>Study protocol is not available, but it is clear that published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon). </p> </li> </ul> </li> <li> <p>High risk of bias－any of the following:</p> <ul id="CD008481-lst2-0007"> <li> <p>Not all pre‐specified primary outcomes of the study have been reported.</p> </li> <li> <p>One or more primary outcomes are reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that were not pre‐specified. </p> </li> <li> <p>One or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect). </p> </li> <li> <p>One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis. </p> </li> <li> <p>Study report fails to include results for a key outcome that would be expected to have been reported for such a study. </p> </li> </ul> </li> <li> <p>Unclear: information is insufficient to allow investigators to conclude 'low risk of bias' or 'high risk of bias' </p> </li> </ul> </p> </section> <section id="CD008481-sec4-0008"> <h5 class="title">Other potential threats to validity</h5> <p>Was the study free from other problems that could put it at risk of bias?</p> <p> <ul id="CD008481-lst1-0012"> <li> <p>Low risk of bias: Study appears to be free from other sources of bias.</p> </li> <li> <p>High risk of bias: One or more important risks of bias are included (e.g. extreme baseline imbalance). </p> </li> <li> <p>Unclear: Information is insufficient to allow investigators to assess whether there is an important risk of bias. </p> </li> </ul> </p> <p>An overall assessment of the level of bias in the included trials was performed to determine the reliability and validity of the data. </p> </section> </section> <section id="CD008481-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>All outcomes were dichotomous; therefore, the measure of treatment effect calculated was risk ratio (RR) with an associated 95% confidence interval (95% CI) using a random‐effects model. A random‐effects model was conducted for all analyses to account for the underlying heterogeneity of included studies, in which different participant populations, antibiotics, and infections were studied. Also, most of the studies were small; therefore, it was thought that a random‐effects model would be less likely to diminish the importance of an observed effect because the weights assigned to each study would be more balanced. </p> </section> <section id="CD008481-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <p>The participant was the unit of analysis. Data from all randomly assigned participants were used for analyses. Scenarios in which censoring or exclusion of data was possible and whether results were presented as the total number of events or the total number of participants with a first event were examined closely. Authors of the studies were contacted regarding any ambiguity. </p> </section> <section id="CD008481-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>Authors of the studies were contacted via e‐mail to clarify and provide any missing data. </p> </section> <section id="CD008481-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>The I<sup>2</sup> statistic and the Chi<sup>2</sup> test were used to test for heterogeneity in the included studies. The threshold for the I<sup>2</sup> statistic was &gt; 50% for important heterogeneity to be considered. The threshold for the Chi<sup>2</sup> statistic was P &lt; 0.10 for important heterogeneity to be considered. When heterogeneity was detected (Chi<sup>2</sup> test value of P &lt; 0.10 or I<sup>2</sup> &gt; 50%), a random‐effects model was used to confirm whether a statistically significant difference between the effects of continuous infusion and those of intermittent infusion could be noted. Clinical and methodological sources of heterogeneity were investigated, including baseline risk factors for outcome measures, study duration, age, race, and sex distribution of participants across studies. </p> <p>Initially, a fixed‐effect meta‐analysis was planned because the default for all analyses and a random‐effects model would be used only when heterogeneity was detected. However, a random‐effects model was used as the default because a large number of small studies with between‐study heterogeneity (e.g. different infections and antibiotics between studies) were used. Fixed‐effect analyses were conducted to determine if there were differences between models because it is possible that small positive studies may drive the meta‐analysis to look more positive as small studies may be given more weight when a random‐effects model is used. </p> </section> <section id="CD008481-sec3-0014"> <h4 class="title">Assessment of reporting biases</h4> <p>Funnel plots were produced to detect potential publication bias. Any asymmetry noted in the plot was investigated to identify possible reasons for the asymmetry (i.e. true heterogeneity of treatment effect, play of chance, poor methodology in included studies). </p> </section> <section id="CD008481-sec3-0015"> <h4 class="title">Data synthesis</h4> <p>Review Manager 5 (<a href="./references#CD008481-bbs2-0090">RevMan 2008</a>) was used to perform all data syntheses and analyses. Risk ratios for dichotomous clinical outcomes were calculated and are presented with 95% confidence intervals. GRADEpro (<a href="./references#CD008481-bbs2-0075">GRADEpro 2008</a>) was used to generate the 'summary of findings' table. </p> </section> <section id="CD008481-sec3-0016"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Any heterogeneity detected was investigated for possible reasons (<a href="./references#CD008481-bbs2-0077">Higgins 2003</a>). Aspects of trials assessed included antibiotic choice, infections being treated, use of other open‐label antibiotics, and dose/duration of antibiotic therapy. A subgroup analysis of trials that included septic participants versus non‐septic participants was conducted to determine whether differences in effect were based on this variable. </p> </section> <section id="CD008481-sec3-0017"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were performed for primary outcomes only. Sensitivity analyses were performed to determine the impact of the presence or absence of appropriate allocation concealment procedures on all‐cause mortality and infection recurrence effect estimates. Sensitivity analyses were also performed to determine the impact of trials studying extended interval infusions compared with intermittent infusions and the impact of the use of other open‐label antibiotics in studies. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008481-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008481-sec1-0005"></div> <section id="CD008481-sec2-0007"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD008481-sec2-0018">Characteristics of included studies</a>; <a href="./references#CD008481-sec2-0019">Characteristics of excluded studies</a>. </p> <section id="CD008481-sec3-0018"> <h4 class="title">Results of the search</h4> <p>The searches conducted in January 2010 identified 2935 records and 6 additional records from other sources. After removal of 1133 duplicate records, 1808 records were screened.&nbsp;The titles and abstracts for these results were screened by four appraisers; initially, 1752 studies were excluded for not meeting the pre‐defined inclusion criteria.&nbsp;The full texts of the remaining 56 potentially eligible studies were retrieved for further assessment.&nbsp;Of 56 potentially eligible studies, 26 studies met the pre–specified inclusion criteria and were included in this review (<a href="#CD008481-fig-0001">Figure 1</a>). Two trials were translated from French into English. However, only a partial translation of 1 trial from Japanese into English could be obtained. An updated search conducted in September 2012 identified 326 records and 3 additional records from other sources. After removal of 102 duplicate records, 227 records were screened and 4 full text articles were retrieved for further assessment. Of the 4 potentially eligible studies, 3 studies were included in this review (<a href="#CD008481-fig-0001">Figure 1</a>). No trials from the updated search required translation into English. A total of 29 studies were included in this review from searches conducted in January 2010 and September 2012. A search of an online clinical trials register (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) and the Internet identified 8 ongoing studies as of November 2012 that may meet inclusion criteria for this review. </p> <div class="figure" id="CD008481-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"><img data-id="CD008481-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG01.png" alt="Continuous vs intermittent study flow diagram."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Continuous vs intermittent study flow diagram.</p> </div> </div> </div> </section> <section id="CD008481-sec3-0019"> <h4 class="title">Included studies</h4> <p>Of the 29 included studies, 25 studies compared continuous antibiotic infusions with traditional intermittent infusions, and 4 studies compared extended antibiotic infusions with intermittent infusions. Hospitalised patients were studied in the 29 included trials, and 19 of these trials studied patients admitted to a critical care unit.&nbsp;The population size of each study ranged from 7 to 262 patients; 4 studies had a study sample size greater than 100 patients.&nbsp;The studies included adults between the ages of 18 and 80 years, with the exception of one trial (<a href="./references#CD008481-bbs2-0008">Feld 1977</a>), which included patients aged 15 years and older. This trial was included in the analysis because the median participant age was 43 to 46 years; therefore, it was thought that very few patients younger than 18 years participated in the study.&nbsp;The percentage of males in the included studies ranged from 43% to 82%.&nbsp; </p> <p>Types of infections studied in the included trials were pneumonia (n = 16), septicemia (n = 13), urinary tract infection (n = 3), skin and soft tissue infection (n = 2), peritonitis (n = 2), acute exacerbation of chronic obstructive pulmonary disease (n = 2), acute exacerbation of chronic bronchitis (n = 1), fever of unknown origin (n = 1), cholangitis (n = 1), sinusitis (n = 1), perirectal infection (n = 1), intra–abdominal or periappendiceal abscess (n = 1), complicated perforated diverticulitis (n = 1), shock lung (n = 1), endocarditis (n = 1), melioidosis (n = 1), catheter‐related infection (n = 1), mediastinitis (n = 1), post‐operative surgical infection (n = 1), and meningitis or central nervous system infection (n = 1).&nbsp; Organisms isolated included <i>Enterococcus faecalis</i>, <i>Enterococcus faecium,</i> coagulase‐negative<i>Staphylococcus</i> (CoNS), <i>Staphylococcus aureus,</i> methicillin–resistant<i>Staphylococcus aureus</i> (MRSA), <i>Burkholderia</i>, <i>Escherichia coli</i>, <i>Klebsiella pneumoniae, Pseudomonas aeruginosa,</i> Enterobacteriaceae, <i>Proteus mirabilis</i>, <i>Citrobacter</i>, <i>Serratia marcescens</i>, <i>Acinetobacter</i>, <i>Clostridium</i>, <i>Haemophilus influenzae</i>, <i>Aeromonas</i>, <i>Moraxella catarrhalis</i>, <i>Morganella morganii, Enterobacter, Salmonella</i>, <i>Streptococcus viridans</i>, <i>Streptococcus milleri, Streptococcus mitis, Streptococcus pneumoniae, Stenotrophomonas, Bacteroides</i>, and <i>Peptostreptococcus</i>.&nbsp;Antibiotics studied included ceftazidime (n = 8), piperacillin‐tazobactam (n = 5), meropenem (n = 3), tobramycin (n = 2), piperacillin (n = 1), linezolid (n = 1), carbenicillin (n = 1), cefamandole (n = 1), temocillin (n = 1), sisomicin (n = 1), cefepime (n = 1), cefoperazone (n = 1), ceftriaxone (n = 1), imipenem (n = 1), cefotaxime (n = 1), gentamicin (n = 1), and vancomycin (n = 1).&nbsp;Open–label antibiotics were permitted in 17 studies, although the remaining included studies did not indicate whether any additional antibiotics were permitted.&nbsp;Antibiotic treatment duration ranged from 4 to 14 days. Follow‐up duration ranged from 24 hours to 28 days but was not reported in 18 studies. </p> <p>Of studies meeting inclusion criteria, 3 studies (<a href="./references#CD008481-bbs2-0014">Lipman 1999</a>; <a href="./references#CD008481-bbs2-0016">Nicolau 1999a</a>; <a href="./references#CD008481-bbs2-0017">Nicolau 1999b</a>) did not report any outcome data. One study (<a href="./references#CD008481-bbs2-0003">Bodey 1979</a>) reported outcomes expressed as episodes and not by participant. This unit of analysis issue could not be reconciled. Therefore, 4 studies that met inclusion criteria did not contribute data to this meta‐analysis. </p> </section> <section id="CD008481-sec3-0020"> <h4 class="title">Excluded studies</h4> <p>Of 60 potentially eligible studies, 31 were excluded after closer examination by 4 independent study appraisers.&nbsp;Studies excluded were cross‐over studies (n = 10), were not randomised (n = 9), used prophylactic antibiotics (n = 3), and included healthy volunteers (n = 2), pharmacoeconomic or cost‐effectiveness analyses (n = 2), pharmacokinetic/pharmacodynamic analyses of already included studies (n = 1), letters to the editor (n = 1), case reports (n = 1), uncontrolled (n = 1), or preliminary analyses of an already included study (n = 1). </p> </section> </section> <section id="CD008481-sec2-0008"> <h3 class="title">Risk of bias in included studies</h3> <p>Most included studies were judged to be at unclear or high risk of bias with regard to randomisation sequence generation, allocation concealment, blinding, management of incomplete outcome data, selective outcome reporting, and other potential threats to validity (86%, 76%, 97%, 69%, 76%, and 90% of studies, respectively). No studies were judged to be at low risk of bias for all methodological quality items assessed. </p> <p>See 'Risk of bias' tables and 'Risk of bias' graphs (<a href="#CD008481-fig-0002">Figure 2</a>, <a href="#CD008481-fig-0003">Figure 3</a>) for additional details regarding evaluation of the included studies. </p> <div class="figure" id="CD008481-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"><img data-id="CD008481-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG02.png" alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <div class="figure" id="CD008481-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"><img data-id="CD008481-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG03.png" alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD008481-sec3-0021"> <h4 class="title">Allocation</h4> <p><b>Generation of randomisation sequence</b> </p> <p>Four trials (<a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0014">Lipman 1999</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>) adequately described generation of allocation sequence procedures and were judged to be at low risk of bias.&nbsp;Four trials (<a href="./references#CD008481-bbs2-0017">Nicolau 1999b</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>) did not describe randomisation methods or generation of allocation sequence methods and were judged to have an unclear risk of bias.&nbsp;The remaining 21 studies were randomised, but randomisation methods were not reported or could not be translated into English, and these studies were judged to have an unclear risk of bias.&nbsp;For additional details, refer to information presented in 'Risk of bias' tables. </p> <p><b>Allocation concealment</b> </p> <p>Six studies (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>) used sealed, opaque envelopes to conceal randomisation allocation and were judged to be at low risk of bias.&nbsp;Five trials (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0003">Bodey 1979</a>; <a href="./references#CD008481-bbs2-0004">Buck 2005</a>; <a href="./references#CD008481-bbs2-0009">Feld 1984</a>; <a href="./references#CD008481-bbs2-0026">Sakka 2007</a>) used sealed envelopes to conceal randomisation allocation, but opacity of envelopes was not described, and these studies were judged to be at unclear risk of bias.&nbsp;Allocation concealment was not clear in 1 study (<a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>) because only a partial translation from Japanese into English was available. The remaining 17 studies did not describe allocation concealment methods and were judged to be at unclear risk of bias. For additional details, refer to information presented in 'Risk of bias' tables. </p> </section> <section id="CD008481-sec3-0022"> <h4 class="title">Blinding</h4> <p>Fourteen studies (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0004">Buck 2005</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0015">Lubasch 2003</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>) were not blind and were judged to be at high risk of bias.&nbsp;One study (<a href="./references#CD008481-bbs2-0016">Nicolau 1999a</a>) was single blind and was judged to be at high risk of bias.&nbsp;Another study (<a href="./references#CD008481-bbs2-0022">Roberts 2007</a>) was double blind and was judged to be at low risk of bias. Blinding was not clear in 1 study (<a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>) because only a partial translation from Japanese into English was available.&nbsp;The remaining 12 studies did not comment on blinding and were judged to be at unclear risk of bias.&nbsp;For additional details, refer to information presented in 'Risk of bias' tables. </p> </section> <section id="CD008481-sec3-0023"> <h4 class="title">Incomplete outcome data</h4> <p>Participants were lost to follow‐up or were censored in 12 trials (<a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0009">Feld 1984</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0011">Hanes 2000</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0015">Lubasch 2003</a>; <a href="./references#CD008481-bbs2-0016">Nicolau 1999a</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>) and were judged to be at unclear or high risk of bias.&nbsp;One trial (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>) included participants who did not complete the study and was judged to be at unclear risk of bias.&nbsp;Two studies (<a href="./references#CD008481-bbs2-0003">Bodey 1979</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>) did not report all pre–specified outcomes for all participants and were judged to be at high risk of bias.&nbsp;Nine studies (<a href="./references#CD008481-bbs2-0004">Buck 2005</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0017">Nicolau 1999b</a>; <a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>) yielded complete outcome data and were judged to be at low risk of bias.&nbsp;Five studies (<a href="./references#CD008481-bbs2-0014">Lipman 1999</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>;<a href="./references#CD008481-bbs2-0026">Sakka 2007</a>; <a href="./references#CD008481-bbs2-0028">Wright 1979</a>) did not report on attrition bias and were judged to be at unclear risk of bias.&nbsp;For additional details, refer to information presented in 'Risk of bias' tables. </p> <p>The corresponding authors of 25 studies were contacted via e‐mail to clarify and provide missing outcome data. Nine authors replied with the requested missing data, which were incorporated into the analyses. Five authors stated that the requested missing data were no longer available, and the remaining authors did not respond. </p> <p>No authors of the 8 ongoing studies were contacted, and no data from these unpublished or ongoing trials were included, because it was not clear from the current information provided whether these trials will meet inclusion criteria for this review. When the full texts of these studies become available, they will be considered for future updates. </p> <p>It is important to note that a substantial amount of information was not available for the pre‐specified outcome measures of this review. Data from all 29 RCTS were not reported for any outcome measures. See table below. </p> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Outcome</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Number of trials reporting outcomes (of a total of 29 possible trials)</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All‐cause mortality</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Infection recurrence</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Clinical cure</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Super‐infection</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adverse events</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Serious adverse events</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Withdrawal due to adverse events</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> </tr> </tbody> </table> </div> </p> </section> <section id="CD008481-sec3-0024"> <h4 class="title">Selective reporting</h4> <p>Seven studies (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0015">Lubasch 2003</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>) reported all pre–specified outcomes and were judged to be at low risk of bias.&nbsp;Seven studies (<a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0014">Lipman 1999</a>; <a href="./references#CD008481-bbs2-0016">Nicolau 1999a</a>; <a href="./references#CD008481-bbs2-0026">Sakka 2007</a>; <a href="./references#CD008481-bbs2-0028">Wright 1979</a>) reported outcomes that were not pre–specified and were judged to be at unclear or high risk of bias. Five studies (<a href="./references#CD008481-bbs2-0011">Hanes 2000</a>; <a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0017">Nicolau 1999b</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>) did not report all pre–specified outcomes and were judged to be at unclear or high risk of bias.&nbsp;Three studies (<a href="./references#CD008481-bbs2-0003">Bodey 1979</a>; <a href="./references#CD008481-bbs2-0009">Feld 1984</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>) did not report the total numbers of participants or participants in each group and were judged to be at high or unclear risk of bias.&nbsp;Five studies (<a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>) did not describe methods, including outcomes, and were judged to be at unclear risk of bias.&nbsp;One study (<a href="./references#CD008481-bbs2-0004">Buck 2005</a>) did not assess clinical outcomes and was judged to be at unclear risk of bias. Selective reporting was not clear in 1 study (<a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>) because only a partial translation from Japanese into English was available.&nbsp;For additional details, refer to information presented in 'Risk of bias' tables. </p> </section> <section id="CD008481-sec3-0025"> <h4 class="title">Other potential sources of bias</h4> <p>No other potential sources of bias were identified in 3 studies (<a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>), which were judged to be at low risk of bias. Other potential sources of bias were not clear in 1 study (<a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>) because only a partial translation from Japanese into English was available.&nbsp;The remaining 25 studies included participant baseline imbalances, unclear use of open–label antibiotics, or pharmaceutical company funding and were judged to be at unclear or high risk of bias. For additional details, refer to information presented in 'Risk of bias' tables. </p> </section> </section> <section id="CD008481-sec2-0009"> <h3 class="title" id="CD008481-sec2-0009">Effects of interventions</h3> <p>See: <a href="./full#CD008481-tbl-0001"><b>Summary of findings for the main comparison</b> Continuous versus Intermittent Antibiotic Infusions for Treatment of Severe Bacterial Infections</a> </p> <p>Intention‐to‐treat analyses were conducted for all outcomes using the total numbers of participants randomly assigned to each intervention for each included study. All analyses were conduced using a random‐effects model and a fixed‐effect model. One difference between the 2 models in the subgroup analysis of septic versus non‐septic participants reporting clinical cure data was noted. However, no differences between the 2 models were observed in all other analyses, suggesting no bias due to small study effects. </p> <p>Worst‐case scenarios were conducted for primary and secondary outcomes for participants lost to follow‐up or censored. Analyses were conducted only when exact numbers of missing participants were known. </p> <p><b>All–cause mortality</b> (<a href="./references#CD008481-fig-00101">Analysis 1.1</a>) </p> <p>Nineteen studies reported mortality data (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0026">Sakka 2007</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>; <a href="./references#CD008481-bbs2-0028">Wright 1979</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in all–cause mortality were noted when time–dependent antibiotics and concentration–dependent antibiotics were analysed together (n = 1241, pooled relative risk (RR) 0.89, 95% CI 0.67 to 1.20, P = 0.45). No evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 13.86, degrees of freedom (df) = 15, P = 0.54; I<sup>2</sup> = 0%). </p> <p>Seventeen studies compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0026">Sakka 2007</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in all–cause mortality were reported with time–dependent antibiotics (n = 1085, RR 0.87, 95% CI 0.62 to 1.22, P = 0.42).&nbsp; No evidence of statistical heterogeneity was obtained (Chi<sup>2</sup> = 13.47, df = 13, P = 0.41; I<sup>2</sup> = 4%). </p> <p>Two studies compared concentration–dependent antibiotics (<a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0028">Wright 1979</a>).&nbsp;No statistically significant differences in all–cause mortality were found with concentration–dependent antibiotics (n = 156, RR 1.10, 95% CI 0.50 to 2.40, P = 0.82).&nbsp;No evidence of statistical heterogeneity was noted (Chi<sup>2</sup> = 0.09, df = 1, P = 0.76; I<sup>2</sup> = 0%). </p> <p>When the worst–case scenario was calculated for time‐dependent and concentration‐dependent antibiotics, when all missing participants were assumed to have died, no statistically significant differences in all–cause mortality were observed (n = 1241, RR 0.94, 95% CI 0.80 to 1.11, P = 0.49). </p> <p><b>Infection recurrence within 14 days of resolution of primary infection</b> (<a href="./references#CD008481-fig-00102">Analysis 1.2</a>) </p> <p>Eight studies reported infection recurrence data; all of these trials compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in infection recurrence (n = 398, RR 1.22, 95% CI 0.35 to 4.19, P = 0.76) were described, and no evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 0.37, df = 2, P = 0.83; I<sup>2</sup> = 0%). </p> <p>When the worst–case scenario was calculated for time‐dependent antibiotics, and when all missing participants were assumed to have infection recurrence, no statistically significant differences in infection recurrence were observed (n = 398, RR 0.88, 95% CI 0.46 to 1.66, P = 0.69). </p> <p><b>Clinical cure</b> (<a href="./references#CD008481-fig-00103">Analysis 1.3</a>) </p> <p>Fifteen studies reported clinical cure; all of these studies compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0004">Buck 2005</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0015">Lubasch 2003</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>).&nbsp;No statistically significant differences in clinical cure were reported (n = 975, RR 1.00, 95% CI 0.93 to 1.08, P = 0.98). No evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 13.72, df = 14, P = 0.47; I<sup>2</sup> = 0%). </p> <p>A worst‐case scenario is not estimable because it is already assumed that all missing participants did not attain clinical cure. </p> <p><b>Superinfections post–therapy</b> (<a href="./references#CD008481-fig-00104">Analysis 1.4</a>) </p> <p>Twelve studies reported secondary super‐infections post–therapy (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0009">Feld 1984</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0011">Hanes 2000</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>). No statistically significant differences in superinfections post–therapy when time–dependent antibiotics and concentration–dependent antibiotics were analysed together (n = 813, RR 1.08, 95% CI 0.60 to 1.94, P = 0.79). No evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 3.64, df = 6, P = 0.73; I<sup>2</sup> = 0%). </p> <p>Ten studies reported secondary super‐infections in studies comparing time–dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0011">Hanes 2000</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in super‐infections with time–dependent antibiotics were reported (n = 623, RR 0.98, 95% CI 0.53 to 1.83, P = 0.95). No evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 2.81, df = 4, P = 0.59; I<sup>2</sup> = 0%). </p> <p>Two studies reported secondary super‐infections when concentration–dependent antibiotics were compared (<a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0009">Feld 1984</a>). No statistically significant differences in secondary super‐infections were seen with concentration–dependent antibiotics (n = 190, RR 2.20, 95% CI 0.41 to 11.70, P = 0.36). No evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 0.05, df = 1, P = 0.82; I<sup>2</sup> = 0%). </p> <p>When the worst–case scenario was calculated for time‐dependent and concentration‐dependent antibiotics, and when all missing participants were assumed to have secondary super‐infections, no statistically significant differences in infection recurrence were reported (n = 813, RR 1.01, 95% CI 0.73 to 1.40, P = 0.96). </p> <p><b>Serious adverse events</b> (<a href="./references#CD008481-fig-00105">Analysis 1.5</a>) </p> <p>Ten studies reported serious adverse events; all of these studies were conducted to compare time–dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in participants experiencing at least one serious adverse event were observed (n = 871, RR 1.36, 95% CI 0.80 to 2.30, P = 0.26), and no evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 1.00, df = 1, P = 0.32; I<sup>2</sup> = 0%). </p> <p>When the worst–case scenario was calculated for time‐dependent antibiotics, and when all missing participants were assumed to have had a serious adverse event, no statistically significant differences in serious adverse events were noted (n = 871, RR 1.04, 95% CI 0.67 to 1.62, P = 0.85). </p> <p><b>Withdrawals due to adverse events</b> (<a href="./references#CD008481-fig-00106">Analysis 1.6</a>) </p> <p>Ten studies reported withdrawals due to adverse events; all of these studies compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in withdrawals due to adverse events were described (n = 871, RR 2.03, 95% CI 0.52 to 7.95, P = 0.31). Statistical heterogeneity could not be calculated because only one study reported participant withdrawals due to adverse events. </p> <p>When the worst–case scenario was calculated, and when all missing participants were assumed to have withdrawn because of an adverse event, no statistically significant differences in withdrawals due to adverse events were seen (n = 871, RR 0.99, 95% CI 0.66 to 1.50, P = 0.98). </p> <p><b>Adverse events</b> (<a href="./references#CD008481-fig-00107">Analysis 1.7</a>) </p> <p>Five studies reported adverse events; all of these studies were performed to compare time–dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>).&nbsp;No statistically significant differences in adverse events were observed (n = 575, RR 1.02, 95% CI 0.94 to 1.12, P = 0.63), and no evidence of statistical heterogeneity was found (Chi<sup>2</sup> = 0.37, df = 1, P = 0.54; I<sup>2</sup> = 0%).&nbsp; </p> <p>When the worst‐case scenario was calculated, in which all missing participants were assumed to have had an adverse event, no statistically significant differences in adverse events were noted (n = 575, RR 1.02, 95% CI 0.94 to 1.12, P = 0.60). </p> <p><b>Subgroup analysis: septic versus non–septic participants</b> </p> <p>Twenty studies included participants with sepsis (met criteria for systemic inflammatory response syndrome with a documented or suspected infection and/or critically unwell admitted to an intensive care unit) (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0011">Hanes 2000</a>; <a href="./references#CD008481-bbs2-0014">Lipman 1999</a>; <a href="./references#CD008481-bbs2-0016">Nicolau 1999a</a>; <a href="./references#CD008481-bbs2-0017">Nicolau 1999b</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0026">Sakka 2007</a>; <a href="./references#CD008481-bbs2-0028">Wright 1979</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>). </p> <p>Fifteen studies reported mortality in septic participants (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0002">Angus 2000</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0020">Pedeboscq 2001</a>; <a href="./references#CD008481-bbs2-0021">Rafati 2006</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0026">Sakka 2007</a>; <a href="./references#CD008481-bbs2-0028">Wright 1979</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in all–cause mortality were reported when time–dependent antibiotics and concentration–dependent antibiotics were analysed together (n = 721, RR 0.82, 95% CI 0.59 to 1.13, P = 0.23).&nbsp;Four studies reported mortality in non–septic participants (<a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>).&nbsp;No statistically significant differences in all–cause mortality were noted when time–dependent antibiotics and concentration–dependent antibiotics were analysed together (n = 520, RR 1.32, 95% CI 0.67 to 2.61, P = 0.43). </p> <p>Six studies reported infection recurrence in septic participants; all of these trials were conducted to compare time–dependent antibiotics (<a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>). No statistically significant differences in infection recurrence were observed (n = 260, RR 2.90, 95% CI 0.12 to 68.33, P = 0.51).&nbsp;Two studies reported infection recurrence in non–septic participants; all of these trials compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0012">Lagast 1983</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>). No statistically significant differences in infection recurrence were described (n = 138, RR 1.04, 95% CI 0.27 to 3.99, P = 0.95). </p> <p>Ten studies reported clinical cure in septic participants; all of these studies compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0001">Adembri 2008</a>; <a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>).&nbsp;No statistically significant differences in clinical cure were reported (n = 465, RR 1.17, 95% CI 0.99 to 1.37, P = 0.06) when a random‐effects model was used. However, a statistically significant difference favouring intermittent antibiotic infusions was seen when a fixed‐effect model was used (n = 465, RR 1.26, 95% CI 1.02 to 1.55, P = 0.03).&nbsp;Five studies reported clinical cure in non–septic participants; all of these trials compared time–dependent antibiotics (<a href="./references#CD008481-bbs2-0004">Buck 2005</a>; <a href="./references#CD008481-bbs2-0013">Lau 2006</a>; <a href="./references#CD008481-bbs2-0015">Lubasch 2003</a>; <a href="./references#CD008481-bbs2-0019">Okimoto 2009</a>; <a href="./references#CD008481-bbs2-0027">van Zanten 2007</a>).&nbsp;No statistically significant differences in clinical cure were observed (n = 510, RR 0.96, 95% CI 0.89 to 1.04, P = 0.36). </p> <p>Ten studies reported super‐infection in septic participants; all of these studies compared time‐dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0010">Georges 2005</a>; <a href="./references#CD008481-bbs2-0011">Hanes 2000</a>; <a href="./references#CD008481-bbs2-0018">Nicolau 2001</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;No statistically significant differences in super‐infection were described (n = 623, RR 0.98, 95% CI 0.53 to 1.83, P = 0.95).&nbsp;Two studies reported super‐infection in non–septic participants; all of these studies compared concentration‐dependent antibiotics (<a href="./references#CD008481-bbs2-0008">Feld 1977</a>; <a href="./references#CD008481-bbs2-0009">Feld 1984</a>). No statistically significant differences in super‐infection were reported (n = 190, RR 2.20, 95% CI 0.41 to 11.70, P = 0.36). </p> <p>Eight studies addressed serious adverse events and withdrawals due to adverse events in septic participants; all of these compared time‐dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0006">Cousson 2005</a>; <a href="./references#CD008481-bbs2-0007">DeJongh 2008</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0023">Roberts 2009b</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>; <a href="./references#CD008481-bbs2-0029">Wysocki 2001</a>).&nbsp;However, no serious adverse events or withdrawals due to adverse events were recorded in these studies; therefore, comparison with non–septic participants could not be performed.&nbsp; </p> <p>Four studies reported adverse events in septic participants; all of these studies compared time‐dependent antibiotics (<a href="./references#CD008481-bbs2-0005">Chytra 2012</a>; <a href="./references#CD008481-bbs2-0022">Roberts 2007</a>; <a href="./references#CD008481-bbs2-0024">Roberts 2009c</a>; <a href="./references#CD008481-bbs2-0025">Roberts 2010</a>). No statistically significant differences in adverse events were observed (n = 313, RR 0.83, 95% CI 0.37 to 1.85, P = 0.66). One study, which compared time‐dependent antibiotics, reported adverse events in non‐septic participants (<a href="./references#CD008481-bbs2-0013">Lau 2006</a>).&nbsp;No statistically significant differences in adverse events were noted (n = 262, RR 1.02, 95% CI 0.94 to 1.12, P = 0.60). </p> <p><b>Sensitivity analysis</b> </p> <p>When studies that did not report allocation concealment procedures were removed from analysis, no statistically significant differences in all–cause mortality were reported (n = 521, RR 1.00, 95% CI 0.63 to 1.58, P = 1.00) nor were differences in infection recurrence described (n = 243, RR 2.90, 95% CI 0.12 to 68.33, P = 0.51). </p> <p>When studies that compared extended interval infusions with intermittent infusions were removed from analysis, no statistically significant differences in all–cause mortality (n = 1187, RR 0.90, 95% CI 0.65 to 1.25, P = 0.53) or infection recurrence were found (n = 398, RR 1.22, 95% CI 0.35 to 4.19, P = 0.76). </p> <p>When studies that stated that open–label antibiotics were permitted were removed from analysis, no statistically significant differences in all–cause mortality (n = 546, RR 1.37, 95% CI 0.71 to 2.67, P = 0.35) or infection recurrence were described (n = 164, RR 1.04, 95% CI 0.27 to 3.99, P = 0.95). </p> <p>The <a href="./references#CD008481-bbs2-0008">Feld 1977</a> study included some participants younger than 18 years; therefore, it was removed from analysis. When removed, no statistically significant differences in all‐cause mortality were seen (n = 1121, RR 0.87, 95% CI 0.64 to 1.18, P = 0.37). This study did not contribute data to the infection recurrence outcome. </p> <p>The <a href="./references#CD008481-bbs2-0013">Lau 2006</a> and <a href="./references#CD008481-bbs2-0015">Lubasch 2003</a> studies reported clinical success as a composite outcome of clinical cure and clinical improvement, and these studies were removed from the analysis.&nbsp;When they were removed, no statistically significant differences in clinical cure were reported (n = 632, RR 1.06, 95% CI 0.94 to 1.19, P = 0.36). </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008481-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008481-sec1-0006"></div> <section id="CD008481-sec2-0010"> <h3 class="title" id="CD008481-sec2-0010">Summary of main results</h3> <p>No differences in all–cause mortality, infection recurrence, clinical cure, or super‐infection post–therapy were found between continuous antibiotic infusions and intermittent antibiotic infusions.&nbsp;Nor were differences reported when safety outcomes (serious adverse events, withdrawals due to adverse events, and adverse events) were compared.&nbsp;When comparisons between time–dependent and concentration–dependent antibiotics were made, no differences in all–cause mortality or super‐infection post–therapy were noted. </p> <p>Subgroup analyses revealed no differences in all–cause mortality, infection recurrence, or super‐infection post–therapy when septic or critical care participants were compared with non–septic participants. A difference was observed in the subgroup analyses of clinical cure in septic versus non‐septic participants. However, this result was not robust because it was not observed in both random‐effects and fixed‐effect models. Additionally, this result is difficult to interpret because clinical cure was a subjective outcome, and no standard definition was used in the included studies. Clinical cure was defined by clinician judgement as improvement in signs and symptoms of infection, which included assessment of some or all of the following factors: bacteriological eradication, leukocyte counts, vital signs, inflammation, and sputum production. In addition, clinical success was defined as a composite outcome of clinical cure and clinical improvement in two studies. Therefore, it cannot be concluded from these data that greater clinical cure was seen in the intermittent antibiotic infusion group. It is also unclear whether any clinically meaningful differences in clinical cure were noted between continuous antibiotic infusions and intermittent antibiotic infusions because of identified risks of bias due to outcome subjectivity and lack of a robust statistical finding. </p> <p>No differences between continuous and intermittent antibiotic infusions were reported for any sensitivity analyses performed. </p> </section> <section id="CD008481-sec2-0011"> <h3 class="title" id="CD008481-sec2-0011">Overall completeness and applicability of evidence</h3> <p>A wide range of antibiotics, infections, and organisms were included in this review, and this may allow the results to be broadly generalized.&nbsp;Although continuous infusions are thought to optimise the pharmacokinetic and pharmacodynamic parameters of time–dependent antibiotics, both time–dependent and concentration–dependent antibiotics were included in this analysis, because there is some thought that a lower total daily antibiotic dose could be used during continuous infusions (<a href="./references#CD008481-bbs2-0089">Nicolau 1996</a>).&nbsp;This would affect the peak concentration and the area under the curve (estimate of drug exposure) for a drug; therefore, concentration–dependent antibiotics were included to investigate whether any adverse clinical outcomes or effects related to continuous infusions of concentration–dependent antibiotics were noted.&nbsp;Additionally, because the continuous infusion of concentration–dependent antibiotics has not been widely studied, it is not clear whether this dosing strategy would be beneficial or harmful to patients.&nbsp;The results of this study are applicable only to hospitalised patients and may not be applied to outpatient parenteral therapy programs based on the types of patients and settings of trials included in this review. &nbsp; </p> <p>Several other concerns surround the applicability of these results.&nbsp;One concern is the heterogeneous definition of clinical cure in each study.&nbsp;Measuring an outcome such as clinical cure is especially difficult when clinicians or outcome assessors are not blinded, which was the case in most of the studies included in this review.&nbsp;Also, the use of open–label antibiotics in many of the studies may bias the effect of the intervention to show no difference.&nbsp;However, it would be unethical to limit antibiotic use in patients with severe bacterial infection.&nbsp;Another factor not considered in this review was pathogen susceptibility. It is possible that a difference between interventions was not observed as more highly susceptible pathogens were studied.&nbsp;Outcomes would theoretically be more similar between groups if the pathogens were highly susceptible (i.e. organisms were very sensitive to the effects of study antibiotics) because any suitable antibiotic would be effective no matter the dosing strategy.&nbsp;It could be hypothesized that continuous antibiotic infusions would be of greater benefit in cases of less susceptible organisms.&nbsp;Other confounding factors are the numerous other therapeutic interventions in hospitalised and critically ill patients (such as fluid resuscitation, vasopressor and inotrope use, and blood transfusion) that could also have a substantial impact on mortality, infection recurrence, and clinical cure.&nbsp;This is an important issue despite the fact that only randomised studies were included, because the validity of randomisation is affected by the small size of the included studies. </p> <p>Although all of the trials included were randomised, it is of note that most of the studies had small participant populations.&nbsp;Generally, fewer than 100 participants were included in each study, and in one case, as few as seven participants were included. This is a potential problem because it raises the issue of whether the pooling of small studies for this review has sufficient power to detect a difference between continuous and intermittent antibiotic infusions. It is not clear whether the sample size as a result of pooling would be able to detect differences between the two antibiotic dosing strategies. This becomes an important issue when the safety outcomes of this review are interpreted because only two studies analysed reported participants experiencing an adverse effect or a serious adverse event, and only one study reported participant withdrawal due to an adverse event. This potential under–reporting of safety outcomes makes it difficult to assess the safety of continuous antibiotic infusions and intermittent antibiotic infusions in severe bacterial infection. &nbsp;&nbsp; </p> <p>Furthermore, for each outcome, the calculated effect estimates in this review are associated with wide confidence intervals and show no particular consistent trend in beneficial or harmful effects with either continuous or intermittent administration. If data were available for outcomes from the trials that did not report on these outcomes, more precise effect estimates could have been calculated and could possibly show advantages or disadvantages for either continuous or intermittent antibiotic administration. It is important to refrain from concluding that outcomes for continuous and intermittent administration are equal, given the quantity of missing information and the possibility that the meta‐analyses are underpowered.&nbsp;&nbsp;&nbsp; </p> <p>In addition to the limitations already described, many logistical concerns have been raised regarding the administration of continuous infusion antibiotics.&nbsp;Some beta–lactams, such as carbapenems, are thought to be too unstable for continuous infusion (<a href="./references#CD008481-bbs2-0098">Viaene 2002</a>).&nbsp;Continuous infusion pumps may increase nursing workload and may limit patient mobility on medical wards, and additional intravenous lines may be required if the antibiotic chosen is not compatible with other medications (<a href="./references#CD008481-bbs2-0069">Ariano 2010</a>). Extending the infusion also occupies an intravenous line that may be essential for other therapies, especially in critically ill patients who have limited intravenous access. As well, it is not known whether continuous infusions would result in increased dosing and administration errors by physicians, pharmacists, and nursing staff. However, several studies have suggested that continuous infusion of antibiotics is more cost–effective compared with intermittent infusions (<a href="./references#CD008481-bbs2-0052">McNabb 2001</a>; <a href="./references#CD008481-bbs2-0073">Florea 2003</a>; <a href="./references#CD008481-bbs2-0079">Hitt 1997</a>; <a href="./references#CD008481-bbs2-0038">Grant 2002</a>). Although intermittent antibiotic infusions are the current standard of therapy, some disadvantages merit consideration. Intermittent antibiotic infusions may increase nursing workload for those antibiotics that require multiple daily doses compared with continuous infusion pumps. In the preparation of these multiple antibiotic doses, the chance of dispensing and mixing errors by pharmacy and nursing staff may be increased. Intermittent infusions typically also result in higher peak concentrations&nbsp;of antibiotics, which could lead to an increase in adverse effects related to drug toxicity. Finally, intermittent antibiotic infusions could put the patient at increased infection risk compared with continuous infusions because more frequent access to intravenous lines is required to give multiple daily doses of antibiotics. </p> </section> <section id="CD008481-sec2-0012"> <h3 class="title" id="CD008481-sec2-0012">Quality of the evidence</h3> <p>The quality of evidence included in this review was very low to moderate according to GRADE considerations (<a href="./references#CD008481-bbs2-0075">GRADEpro 2008</a>; <a href="./references#CD008481-bbs2-0070">Balshem 2011</a>; <a href="./references#CD008481-bbs2-0076">Guyatt 2011</a>).&nbsp;Although all 29 studies were randomised, procedures for both generation of the randomisation sequence and allocation concealment were described in only two studies. Only two studies were blinded, and the remaining studies were not blinded, or blinding was not reported and the studies appeared to be unblinded as judged by the authors.&nbsp;Additionally, accounting of missing participants and missing outcomes was not well described in the studies reviewed. It is interesting to note that many included studies were published before the CONSORT guidelines for reporting of RCTs were available. </p> </section> <section id="CD008481-sec2-0013"> <h3 class="title" id="CD008481-sec2-0013">Potential biases in the review process</h3> <p>This review had a focused objective and used a systematic search strategy to identify studies for potential inclusion.&nbsp;Biases in the review process were minimized by using pre–defined inclusion and exclusion criteria for study selection and standardized data extraction forms to gather data and appraise studies. Although no evidence of statistical heterogeneity was observed for all outcomes studied, several potential sources of heterogeneity (such as variation in outcomes studied, open–label antibiotic use, infection type, and patient co–morbidities) should be considered.&nbsp;Also, the potential for publication bias exists, although the funnel plots for all–cause mortality, infection recurrence, clinical cure, and super‐infection do not seem to indicate this (<a href="#CD008481-fig-0004">Figure 4</a>, <a href="#CD008481-fig-0005">Figure 5</a>, <a href="#CD008481-fig-0006">Figure 6</a>, <a href="#CD008481-fig-0007">Figure 7</a>).&nbsp;Publication bias increases the potential for adverse events, serious adverse events, and withdrawals due to adverse events as a result of the fact that funnel plots could not be analysed because the number of trials reporting these outcomes was insufficient. </p> <div class="figure" id="CD008481-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"><img data-id="CD008481-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG04.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions, outcome. All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions, outcome. All‐cause mortality. </p> </div> </div> </div> <div class="figure" id="CD008481-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"><img data-id="CD008481-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG05.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: infection recurrence."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: infection recurrence. </p> </div> </div> </div> <div class="figure" id="CD008481-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"><img data-id="CD008481-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG06.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: clinical cure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: clinical cure. </p> </div> </div> </div> <div class="figure" id="CD008481-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"><img data-id="CD008481-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG07.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: super‐infection."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: super‐infection. </p> </div> </div> </div> </section> <section id="CD008481-sec2-0014"> <h3 class="title" id="CD008481-sec2-0014">Agreements and disagreements with other studies or reviews</h3> <p>This systematic review is consistent with previously published reviews.&nbsp;A meta–analysis of nine RCTs did not show any statistically significant differences in mortality (OR 0.89, 95% CI 0.48 to 1.64) (<a href="./references#CD008481-bbs2-0081">Kasiakou 2005b</a>).&nbsp;A potential explanation for the similarity of results is that seven of the nine RCTs in the Kasiakou et al study also met inclusion criteria for this review. The remaining two studies were excluded from this review because one study was a cost‐effectiveness re‐analysis of an already included study, and the other study included nonｰrandomly assigned participants.&nbsp;Moreover, four of the five RCTs that reported mortality data were included in this review.&nbsp;Similar antibiotics, such as beta–lactams, aminoglycosides, and vancomycin, were compared in both reviews.&nbsp;Similar participant populations, such as critical care participants, were compared in both reviews. Although no differences in mortality were reported by Kasiakou et al, these authors still concluded that continuous antibiotic infusions have a clinical advantage compared with intermittent infusions.&nbsp;This conclusion was based on a subgroup analysis in which only trials comparing the same total antibiotic dose showed that clinical failure rates were lower in the continuous infusion group (OR 0.70, 95% CI 0.50 to 0.98) (<a href="./references#CD008481-bbs2-0081">Kasiakou 2005b</a>). Conversely, a difference favouring intermittent antibiotic infusions for clinical cure in septic participants was observed in this review. However, as has been discussed, the difference observed was not a robust statistical finding.&nbsp;A larger systematic review of 14 RCTs conducted by Roberts et al also did not find any differences in mortality (OR 1.00, 95% CI 0.48 to 2.06) or clinical cure (OR 1.04, 95% CI 0.74 to 1.46) (<a href="./references#CD008481-bbs2-0093">Roberts 2009a</a>).&nbsp;Again, this similarity is likely related to the fact that 13 of the 14 RCTs in the review by Roberts et al are included in this review. The remaining study was not included in this review because it was not randomised. Therefore, both reviews had similar patient populations, study settings, and antibiotics studied. Tamma et al compared only beta–lactam continuous infusions versus intermittent infusions when conducting another systematic review of 14 RCTs.&nbsp;Similar to this review, Tamma et al did not find any differences in mortality (RR 0.92, 95% CI 0.61 to 1.37) or clinical cure (RR 1.00, 95% CI 0.94 to 1.06) (<a href="./references#CD008481-bbs2-0096">Tamma 2011</a>).&nbsp;Once again, with 12 of the 14 RCTs included in both reviews, this consistency is likely explained. The remaining 2 studies were not included in this review because 1 study was not randomised, and the other study compared different antibiotics, which was an exclusion criterion for this review. </p> <p>Generally, those studies that have shown a trend toward improved outcomes with continuous infusion antibiotics were investigating more resistant organisms in critically ill participants.&nbsp;A cohort study performed by Lodise et al compared 194 participants with a mean APACHE II score of 16, who received piperacillin‐tazobactam extended infusions versus intermittent infusions to treat <i>Pseudomonas aeruginosa</i> (<a href="./references#CD008481-bbs2-0084">Lodise 2007</a>).&nbsp;Lodise et al found that participants with an APACHE II score &gt; 17 receiving piperacillin‐tazobactam extended infusions had a statistically significant benefit in 14–day mortality (P = 0.04) (<a href="./references#CD008481-bbs2-0084">Lodise 2007</a>).&nbsp;However, when the overall 14–day mortality was calculated, no statistically significant difference was noted (P = 0.17) (<a href="./references#CD008481-bbs2-0084">Lodise 2007</a>).&nbsp;Therefore, it could be hypothesized that continuous antibiotic infusions provide clinically meaningful benefit only in the critically ill.&nbsp;However, the subgroup analysis comparing septic or critically ill participants with non–septic participants in this review did not find any differences except for clinical cure in septic participants, which was not robust.&nbsp;A potential explanation for this is that all studies included in this review were RCTs, and the Lodise et al study was a nonｰrandomly assigned retrospective cohort. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008481-fig-0001"> <img data-id="CD008481-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG01.png" alt="Continuous vs intermittent study flow diagram."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Continuous vs intermittent study flow diagram.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-0002"><img data-id="CD008481-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG02.png" alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-0003"><img data-id="CD008481-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG03.png" alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-0004"><img data-id="CD008481-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG04.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions, outcome. All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions, outcome. All‐cause mortality. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0004" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG04.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-0005"><img data-id="CD008481-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG05.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: infection recurrence."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: infection recurrence. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0005" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG05.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-0006"><img data-id="CD008481-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG06.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: clinical cure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: clinical cure. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0006" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG06.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-0007"><img data-id="CD008481-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG07.png" alt="Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: super‐infection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: continuous vs intermittent antibiotic infusions. Outcome: super‐infection. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-fig-0007" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-AFig-FIG07.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00101"><img data-id="CD008481-fig-00101" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-01.png" alt="Comparison 1 Continuous vs intermittent, Outcome 1 All cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 1 All cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00102"><img data-id="CD008481-fig-00102" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-02.png" alt="Comparison 1 Continuous vs intermittent, Outcome 2 Infection recurrence."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 2 Infection recurrence.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00103"><img data-id="CD008481-fig-00103" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-03.png" alt="Comparison 1 Continuous vs intermittent, Outcome 3 Clinical Cure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 3 Clinical Cure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00104"><img data-id="CD008481-fig-00104" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-04.png" alt="Comparison 1 Continuous vs intermittent, Outcome 4 Superinfection."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 4 Superinfection.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00105"><img data-id="CD008481-fig-00105" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-05.png" alt="Comparison 1 Continuous vs intermittent, Outcome 5 Serious Adverse Events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 5 Serious Adverse Events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00106"><img data-id="CD008481-fig-00106" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-06.png" alt="Comparison 1 Continuous vs intermittent, Outcome 6 Withdrawal due to Adverse Events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 6 Withdrawal due to Adverse Events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD008481-fig-00107"><img data-id="CD008481-fig-00107" src="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-07.png" alt="Comparison 1 Continuous vs intermittent, Outcome 7 Adverse Events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Continuous vs intermittent, Outcome 7 Adverse Events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-fig-00107" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD008481.pub2/media/CDSR/CD008481/image_n/nCD008481-CMP-001-07.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD008481-tbl-0001" class="summary-of-findings framed"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Continuous versus Intermittent Antibiotic Infusions for Treatment of Severe Bacterial Infections</span></div> <tbody> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Continuous versus Intermittent Antibiotic Infusions for Treatment of Severe Bacterial Infections</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p><b>Patients:</b> Adults with Severe Bacterial Infections<br> <b>Setting:</b> Hospital<br> <b>Intervention:</b> Continuous Antibiotic Infusions<br> <b>Comparison:</b> Intermittent Antibiotic Infusions </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Intermittent antibiotic Infusions</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Continuous antibiotic Infusions</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>All‐cause mortality</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>131 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>116 per 1000</b> <br> (88 to 157) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 0.89</b> <br> (0.67 to 1.20) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1241<br> (19 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊕⊝<br> <b>moderate</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Infection recurrence</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>19 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>24 per 1000</b> <br> (7 to 81) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.22</b> <br> (0.35 to 4.19) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>398<br> (8 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Clinical cure</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>584 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>608 per 1000</b> <br> (555 to 660) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.04</b> <br> (0.95 to 1.13) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>975<br> (15 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Super‐infection</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>49 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>53 per 1000</b> <br> (29 to 95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.08</b> <br> (0.60 to 1.94) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>813<br> (12 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Serious adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>48 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>65 per 1000</b> <br> (38 to 110) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.36</b> <br> (0.80 to 2.30) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>871<br> (10 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Withdrawal due to adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>7 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>14 per 1000</b> <br> (4 to 54) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 2.03</b> <br> (0.52 to 7.95) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>871<br> (10 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊕⊝⊝<br> <b>low</b> </p> </td> </tr> <tr class="separated"> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>441 per 1000</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>450 per 1000</b> <br> (415 to 494) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR 1.02</b> <br> (0.94 to 1.12) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>575<br> (5 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>⊕⊝⊝⊝<br> <b>very low</b> </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" valign="" colspan="6" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span>&nbsp;<span class="table-title">Continuous versus Intermittent Antibiotic Infusions for Treatment of Severe Bacterial Infections</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/full#CD008481-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD008481-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Continuous vs intermittent</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 All cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1241</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.67, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1085</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.62, 1.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Concentration‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>156</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.10 [0.50, 2.40]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Infection recurrence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>398</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.22 [0.35, 4.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Clinical Cure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>975</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.00 [0.93, 1.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Superinfection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>813</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.08 [0.60, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>623</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.53, 1.83]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Concentration‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>190</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.20 [0.41, 11.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Serious Adverse Events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>871</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.36 [0.80, 2.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Withdrawal due to Adverse Events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>871</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.03 [0.52, 7.95]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Adverse Events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Time‐dependent antibiotics</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>575</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.94, 1.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Continuous vs intermittent</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD008481.pub2/references#CD008481-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> </div> <noscript> <img height="1" width="1" style="display:none" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008481.pub2&rf="/> </noscript> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008481-note-1205">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD008481-note-1204">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a href="#" target="_blank" class="citation-btn-sciwheel at300b btn btn-link disabled" id="sciWheelCitationBtn"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" target="_blank" rel="noopener noreferrer">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> <li class="citation-option" data-option="csv"><button type="button" class="btn btn-link">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://community.cochrane.org/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://www.cochrane.org/">
<img class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2021 by <a href="http://www.wiley.com" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="https://www.wiley.com/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eu.wiley.com/"><img class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div>  <script type='text/javascript'> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id='ZN_cGCHHvWNpnJb1zf'></div>  </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1634809370000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1634809370000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060960000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060986000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060966000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1637060966000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008481\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008481\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008481\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008481\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008481\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1634809370000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <iframe title="scolaris.citation.export.frame" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=zrkx755e&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008481.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008481.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh_HANT, zh_HANS]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT" class="content-language-selector " data-languagecode="zh_HANT">繁體中文</a> <a href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS" class="content-language-selector " data-languagecode="zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD008481.pub2/full/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD008481.pub2/full/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008481.pub2%2Ffull" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://www.cochrane.org/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1638141917483" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x2f;full" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="https://onlinelibrary.wiley.com/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1638141917487" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD008481&#x2e;pub2&#x2f;full" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD008481.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 
